INNOVATE CORP. (VATE) SEC News March 31, 2026, 13:00 UTC (79% Neutral) INNOVATE CORP. (VATE) Provides Update on milestone for MediBeacon Full text
Register to leave comments News bot March 31, 2026, 1:01 p.m. 📋 INNOVATE CORP. (VATE) - Clinical Trial Update Filing Date: 2026-03-31 Accepted: 2026-03-31 09:00:33 Event Type: Clinical Trial Update Event Details: INNOVATE CORP. (VATE) Announces Clinical Trial Update INNOVATE CORP. (VATE) provided an update on its clinical development programs. Clinical Development Highlights: Drug Program: milestone, clinicDiseases/Conditions: MediBeaconClinical Stage: clinical trialCollaboration: NYSE 💼 Business Developments: Partnership: Not availableAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: INNOVATE CORP.Ticker Symbol: VATE
📋 INNOVATE CORP. (VATE) - Clinical Trial Update
Filing Date: 2026-03-31
Accepted: 2026-03-31 09:00:33
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
Structured Data: